Sort
46,585 grants matching “heart failure”
Autocoids in Hypertension: Pathogenesis and End Organ Damage
$2,472,318Oscar A. Carretero · Henry Ford Health System · P01 · FY2016 · HL
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
$2,472,282Rebecca Li · New England Research Institutes, Inc. · N01 · FY2013 · HL
Glycoconjugates and Cardiovascular Disease
$2,470,521Gerald Warren Hart · Johns Hopkins University · P01 · FY2015 · HL
Biology of Long-Term Mechanical Circulatory Support
$2,469,779Yoshifumi Naka · Columbia University Health Sciences · P50 · FY2008 · HL
Genome Transplant Dynamics: non-invasive sequencing-based diagnosis of rejection
$2,463,942Hannah Augusta Valantine · Stanford University · RC4 · FY2010 · AI
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
$2,455,486Jennifer E Van Eyk · Johns Hopkins University · N01 · FY2014 · HL
A Protein Replacement Drug for Friedreichs Ataxia
$2,453,144Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with LEOPARD Syndrome
$2,453,144Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center
$2,447,779Alan Thevenet N. Tita · University Of Alabama At Birmingham · U01 · FY2014 · HL
Glycoconjugates and Cardiovascular Disease
$2,446,900Gerald Warren Hart · Johns Hopkins University · P01 · FY2012 · HL
The ISCHEMIA-CKD Trial-CCC-Lead Application
$2,443,785Sripal Bangalore · New York University School Of Medicine · U01 · FY2015 · HL
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
$2,442,081Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2017 · HL
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
$2,441,087Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2016 · HL
GENERAL CLINICAL RESEARCH CENTER
$2,439,173University Of Vermont &St Agric College · M01 · FY2000 · RR
Protection of Ischemic Myocardium
$2,437,090Roberto Bolli · University Of Louisville · P01 · FY2013 · HL
Glycoconjugates and Cardiovascular Disease
$2,436,266Gerald Warren Hart · Johns Hopkins University · P01 · FY2011 · HL
Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants
$2,435,370Daniel Tamez · Inspired Therapeutics, Llc · R44 · FY2023 · HL
Autocoids in Hypertension: Pathogenesis and End Organ Damage
$2,435,234Oscar A. Carretero · Henry Ford Health System · P01 · FY2015 · HL
A Revolutionary Approach for Polycystic Kidney Disease: Oral Nanotherapeutics
$2,433,330Eun Ji Paige Chung · University Of Southern California · DP2 · FY2018 · DK
Genetically-engineered Pig Organ Transplantation into Non-human Primates
$2,429,398David Kc Cooper · University Of Alabama At Birmingham · U19 · FY2019 · AI
Genetically-engineered Pig Organ Transplantation into Non-human Primates
$2,429,398David Kc Cooper · University Of Alabama At Birmingham · U19 · FY2017 · AI
CaMKII and InsP3-Mediated Signaling in Cardiac Myocytes
$2,429,357Donald M Bers · University Of California At Davis · P01 · FY2012 · HL
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$2,425,096Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2019 · HL
Functional Imaging of The Brain
$2,423,172Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Autocoids in Hypertension: Pathogenesis and End Organ Damage
$2,422,873Oscar A. Carretero · Henry Ford Health System · P01 · FY2014 · HL